Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [41] Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making
    Thomas W. LeBlanc
    Nigel H. Russell
    Loriana Hernandez-Aldama
    Charlotte Panter
    Timothy J. Bell
    Verna Welch
    Diana Merino Vega
    Louise O’Hara
    Julia Stein
    Melissa Barclay
    Francois Peloquin
    Andrew Brown
    Jasmine Healy
    Lucy Morgan
    Adam Gater
    Ryan Hohman
    Karim Amer
    Dawn Maze
    Roland B. Walter
    Oncology and Therapy, 2022, 10 : 421 - 440
  • [42] Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making
    LeBlanc, Thomas W.
    Russell, Nigel H.
    Hernandez-Aldama, Loriana
    Panter, Charlotte
    Bell, Timothy J.
    Welch, Verna
    Vega, Diana Merino
    O'Hara, Louise
    Stein, Julia
    Barclay, Melissa
    Peloquin, Francois
    Brown, Andrew
    Healy, Jasmine
    Morgan, Lucy
    Gater, Adam
    Hohman, Ryan
    Amer, Karim
    Maze, Dawn
    Walter, Roland B.
    ONCOLOGY AND THERAPY, 2022, 10 (02) : 421 - 440
  • [43] Prostate cancer screening and informed decision-making: provider and patient perspectives
    Bowen, D. J.
    Hannon, P. A.
    Harris, J. R.
    Martin, D. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (02) : 155 - 161
  • [44] Prostate cancer screening and informed decision-making: provider and patient perspectives
    D J Bowen
    P A Hannon
    J R Harris
    D P Martin
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 155 - 161
  • [45] Treatment decision-making process of men with newly diagnosed localized prostate cancer: the role of multidisciplinary approach in patient engagement
    Bellardita, Lara
    Villa, Silvia
    De Luca, Letizia
    Donegani, Simona
    Magnani, Tiziana
    Salvioni, Roberto
    Valdagni, Riccardo
    MEDITERRANEAN JOURNAL OF CLINICAL PSYCHOLOGY, 2019, 7 (01):
  • [46] Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment
    Holmes-Rovner, Margaret
    Montgomery, Jeffrey S.
    Rovner, David R.
    Scherer, Laura D.
    Whitfield, Jesse
    Kahn, Valerie C.
    Merkle, Edgar C.
    Ubel, Peter A.
    Fagerlin, Angela
    MEDICAL DECISION MAKING, 2015, 35 (08) : 999 - 1009
  • [47] The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset
    Maarten Cuypers
    Romy E. D. Lamers
    Erik B. Cornel
    Lonneke V. van de Poll-Franse
    Marieke de Vries
    Paul J. M. Kil
    Supportive Care in Cancer, 2018, 26 : 1297 - 1304
  • [48] The effect of health literacy on patient's perceived shared decision-making among Chinese cancer patients
    Xiao, Lin
    Miao, Jingxia
    Peng, Meifang
    Jiang, Haihua
    Liu, Suting
    Liu, Yawei
    Zhang, Lili
    PSYCHO-ONCOLOGY, 2022, 31 (01) : 70 - 77
  • [49] The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset
    Cuypers, Maarten
    Lamers, Romy E. D.
    Cornel, Erik B.
    van de Poll-Franse, Lonneke V.
    de Vries, Marieke
    Kil, Paul J. M.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1297 - 1304
  • [50] Treatment decision-making in breast cancer: the patient–doctor relationship
    L. J. Fallowfield
    Breast Cancer Research and Treatment, 2008, 112 : 5 - 13